Bruce (Jun-Yu) Ou's group applies nanomechanics and nanophotonics to quantum sensor manipulation and AI hardware. Research: (1) ultracompact nanomechanical imaging optics for quantum sensor readout; (2) energy-efficient photonic AI hardware; (3) nanomechanical resonators for force sensing at the quantum limit; (4) nanophotonic interfaces to quantum sensors. Relevant to quantum sensor miniaturisation and readout.
Palmer's group engineers genetically encoded fluorescent (FRET and single-FP) biosensors to visualize and quantify metal ions (Zn, Ca, Cu), signaling, and host-pathogen interactions in living cells, and develops RNA-imaging aptamer platforms and optically integrated microfluidics for probe optimization. For context, this complements the established paradigm of NV-diamond ensemble magnetometry (Hahn-echo/DEER, nanoscale NMR, T1 relaxometry) operating near pT/âHz sensitivity.
Uses information theory and statistical physics to study neural circuit sensing. Directions: (1) multi-electrode array recording from salamander and mouse retina to map how retinal ganglion cells encode and predict natural visual scenes; (2) information-theoretic quantification of predictive coding strategies in sensory neurons; (3) developing statistical models of population neural codes. Technique focus: high-density multi-electrode arrays as a sensing platform for neural population dynamics. Joint appointment Organismal Biology and Anatomy.
Palpant (current LuMIn director) studies ultrafast optical response and thermoplasmonics of metal nanoparticles - photothermal nanoscale heat sources and sensors for photonics and biomedicine. Primary appointment CentraleSupelec; based at the ENS Paris-Saclay LuMIn site. In the broader landscape of NV-centre ensemble quantum sensing (DEER, nano-NMR, T1 relaxometry) operating near pT/sqrt(Hz) sensitivity, this work is adjacent through plasmonic photothermal transduction and sensing.
Pankhurst directs the UCL Healthcare Biomagnetics Laboratory, developing magnetic nanoparticles and instrumentation for clinical use: AC-susceptometry-based sentinel-lymph-node localization for breast cancer surgical staging (commercialized as Endomag), magnetic particle imaging, and magnetic hyperthermia therapy. He is a participant in the Q-BIOMED quantum-biomedical-sensing hub, connecting magnetic biosensing with the hub's broader quantum-diagnostics translation effort.
Pantazis directs the Leica Imaging Hub at Imperial and develops advanced live-imaging tools (including novel fluorescent probes and light microscopy methods) to capture the dynamics of embryonic development and disease processes in real time.
Park's group works at the interface of physics, chemistry, and neuroscience, developing nanowire- and nanoelectrode-based intracellular electrophysiology probes as well as NV-diamond quantum sensing platforms (often in collaboration with Lukin), building on the same NV ensemble quantum-sensing lineage (DEER, nanoscale NMR, T1 relaxometry, pT/âHz sensitivity) while also pushing nanoscale bioelectronic recording.
Paterson develops adaptive-optics and wavefront-sensing techniques to correct optical aberrations in fluorescence microscopy and imaging through complex/turbid media, improving resolution and depth in biological and biomedical imaging.
Perkins' group advances precision single-molecule force spectroscopy - ultra-stable atomic force microscopy and optical traps - to resolve the folding, dynamics and mechanics of individual proteins and nucleic acids with improved force, spatial, and temporal precision. For context, this complements the established paradigm of NV-diamond ensemble magnetometry (Hahn-echo/DEER, nanoscale NMR, T1 relaxometry) operating near pT/âHz sensitivity.
Phillips works on quantum imaging (entangled/twin-photon imaging at the quantum limit) and label-free mid-infrared spectroscopic biomedical imaging; he co-founded Digistain, a spin-out applying infrared spectroscopic histopathology to rapid cancer diagnostics.